Strategic Partners Target expansion opportunities with tertiary suppliers and paper groups connected to Sorbent Therapeutics, such as Linfox and Asia Pulp & Paper (APP), to explore co-development or distribution deals leveraging their logistics and sustainability networks.

Sustainability Leverage Position the company’s Rapidly Renewable Fibre initiatives and sustainability partnerships as differentiators to win contracts with eco-conscious buyers in the tissue and packaging value chain seeking low-impact, non-absorbed polymeric drug platforms for ancillary applications.

Private Funding Access Engage potential strategic investors or grant-aligned funds by highlighting the $110M funding base and the early-stage revenue potential, to unlock collaborations, milestone-based partnerships, or licensing deals in large CHF/CKD/ESRD markets.

Clinical Market Fit Identify near-term sales opportunities by mapping Sorbent’s targets (CHF, CKD, ESRD, Hypertension) to contract research organizations, hospital networks, and specialty clinics that could pilot non-absorbed polymeric drug candidates as adjunctive therapies or device-like sequestration solutions.

Brand & Outreach Leverage recent branding and agency activity to accelerate outreach campaigns, focusing on thought leadership, partnerships, and sustainability storytelling to open door opportunities with regional distributors and strategic accounts in Asia Pacific and Australia.